Myia is a data driven operating system for virtual care. Myia equips Patients and Clinicians with the tools needed for the patients transition from hospital at home, to 30 day readmit avoidance, to traditional RPM. The shift to value-based reimbursement models necessitates more preventative models of care, Myia's platform crosses these models and facilitates cost savings. Myia is partnering with the leading healthcare organizations around the country. Partners like Mercy Virtual, one of the country's leaders in continuous and preventative chronic care management, including patients with Heart Failure, COPD, Diabetes, and Hypertension. Myia improves quality of life for patients and predicts and prevents costly medical events for care providers. Myia takes a device agnostic approach to daily patient monitoring, applies proprietary machine learning for smart triage, and has a clinician centric application to surface the right patient at the right time into workflow. Partnerships with BioIntellisense and Dispatch health bring a complete Hospital at Home offering to the market.

Web-based clinical intelligence platform, primarily utilized in critical care units to guide clinical decisions. The platform has full interoperability with the Electronic Health Record, and combines all relevant data within the complex critical care environment into one visualization to provide a full picture of a patient and their longitudinal trends. FDA-cleared algorithms continually assess the incoming patient information and provide early warning signs of clinical deterioration to aid care teams with determining interventions and treatment. Automated clinical workflows, customized to each individual ICU, provide care efficiency and positively impact clinical outcomes. 

Published clinical outcomes showing:

• Up to 36% reduction in ICU length of stay
• 41% reduction in ICU readmissions
• 22% reduction in time on ventilation
• 18% reduction in time on vasoactive medication

Commercial stage company with market leading AI clinical decision support platform for bedside and remote monitoring of high acuity patients. Published outcomes and strong ROI; utilized in 40+ hospitals & health systems.

There are no homegrown options that do all that Myia is capable of from a Clinical Perspective. Myia can be used to monitor patient data in four major settings, Inpatient, Hospital at Home, 30 Day readmit avoidance programs, long term RPM programs.

Myia is the only RPM vendor that we are aware of with Data Scientist on staff as well as Data Analyst who work to stratify data and work with Clients to maximize the value of the Myia platform. By looking across patients clinical indication Myia can predict who should be on the program as well as whom is likely to require a hospital visit. These analytics help reduce costs and patient outcomes.

Etiometry provides functionality to seamlessly extend the EHR to be effective for care in high-acuity patient settings (e.g. ICU), including automating clinical workflows, and providing in-depth, longitudinal trends.

Etiometry is the only CDS platform with 4 FDA-cleared risk algorithms and the platform's data collection capabilities have led to a vastly larger number of supporting clinical studies (>150).